Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Forma Therapeutics Holdings, Inc. - Common Stock (NQ:FMTX)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 13, 2022 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	-
Bid (Size)	19.98 (496)
Ask (Size)	20.01 (1,384)
Prev. Close	20.01
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	47,852,557
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Biotech Stocks Well-Positioned For The Fourth Quarter ↗

October 12, 2022

The path of interest rates is clearer for 2022 and the FED is closer to a pause early next year as it calibrates its response from a hammer approach so far.

Via Talk Markets

Novo Nordisk Touts Another Once-Weekly Insulin Icodec Win In Type 2 Diabetes ↗

October 03, 2022

Via Benzinga

Performance

More News

Sickle Cell Disease Association of America & Partners Launch New PSA to Boost Awareness and Understanding of the Disease

September 30, 2022

From Forma Therapeutics, Inc.

Via Business Wire

FORMA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forma Therapeutics, Holdings Inc. - FMTX

September 27, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

4 Analysts Have This to Say About Forma Therapeutics Hldgs ↗

September 02, 2022

Via Benzinga

Recap: Forma Therapeutics Q2 Earnings ↗

August 05, 2022

Via Benzinga

Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin ↗

September 15, 2022

Via Investor's Business Daily

Top Russell 2000 Stocks: Trading Opportunities For Next Week - Sunday, Sept. 11 ↗

September 11, 2022

Via Talk Markets

FORMA THERAPEUTICS INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forma Therapeutics, Holdings Inc. - FMTX

September 02, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2022 ↗

September 02, 2022

Via Benzinga

This Analyst Predicts $700 For Broadcom, Plus RBC Capital Slashes PT On This Stock By 85% ↗

September 02, 2022

Via Benzinga

Dow Turns Higher; Gold Down 1% ↗

September 01, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 01, 2022

Via Benzinga

Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday ↗

September 02, 2022

Via Benzinga

Nasdaq Tumbles 250 Points; Crude Oil Falls Sharply ↗

September 01, 2022

Via Benzinga

Why Okta Is Trading Lower By Over 32%, Here Are 58 Stocks Moving In Thursday's Mid-Day Session ↗

September 01, 2022

Via Benzinga

Novo Nordisk Jumps Into Sickle Cell Fray With $1.1 Billion Forma Therapeutics Buyout ↗

September 01, 2022

Via Investor's Business Daily

Nutanix, Five Below And Some Other Big Stocks Moving Higher On Thursday ↗

September 01, 2022

Via Benzinga

Guardforce AI (GFAI) Stock Gets a Boost From New Exec Team ↗

September 01, 2022

Via InvestorPlace

Forma Therapeutics (FMTX) Stock Soars on Novo Nordisk Acquisition News ↗

September 01, 2022

Via InvestorPlace

After Pfizer, Now Novo Nordisk Beefs Up Its Sickle Cell Portfolio With Forma Therapeutics Deal ↗

September 01, 2022

Via Benzinga

FMTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Forma Therapeutics, Holdings Inc. Is Fair to Shareholders

September 01, 2022

From Halper Sadeh LLP

Via Business Wire

Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders

September 01, 2022

From Forma Therapeutics

Via Business Wire

Forma Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

August 05, 2022

From Forma Therapeutics Holdings, Inc.

Via Business Wire

Earnings Scheduled For August 5, 2022 ↗

August 05, 2022

Via Benzinga

Frequently Asked Questions

Is Forma Therapeutics Holdings, Inc. - Common Stock publicly traded?

Yes, Forma Therapeutics Holdings, Inc. - Common Stock is publicly traded.

What exchange does Forma Therapeutics Holdings, Inc. - Common Stock trade on?

Forma Therapeutics Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Forma Therapeutics Holdings, Inc. - Common Stock?

The ticker symbol for Forma Therapeutics Holdings, Inc. - Common Stock is FMTX on the Nasdaq Stock Market

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.